Presentations

Monday, 28 January 2019
Opening Session: Challenges of Timely and Integrated Testing and Care

Welcome: Conference objectives and overview
Conference Chairs: Daniel Simões, Adrian Streinu-Cercel

Recent trends and testing initiatives in Romania
Minister of Health Romania, Hon. Sorina Pintea

European Commission policy of integration of infectious diseases
Vytenis Andriukaitis, European Commissioner for Health and Food Safety (by video)

Tuesday, 29 January 2019

Plenary Session 1: Epidemiological and Testing Policy Overview: Where are we in reaching the targets?

Monitoring the response to Hepatitis and HIV in Europe and Central Asia: Are we on track to reach agreed targets?
Teymur Noori, European Centre for Disease Prevention and Control (ECDC)

HIV and viral hepatitis response under UHC approach – WHO Guidance on testing strategies and linkage to care
Elena Vovc, WHO Regional Office for Europe

People Who Inject Drugs and prisoners: Priority populations for testing
Jane Mounteney, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

Affordability and cost-effectiveness of hepatitis and HIV testing
Yazdan Yazdanpanah, Institut national de la santé et de la recherche médicale (INSERM)

Plenary Session 2: Combination Treatment

PrEP – effective community mobilization
Will Nutland, PrEPster

HCV Prevention and Testing in Harm Reduction Programs
Jason Farrell, Correlation Network

The evidence behind U=U
Valentina Cambiano, University College London

Implementation of self-testing in the countries of Eastern Europe: Belarusian experience
Viatcheslav Grankov, WHO Country Office in Belarus

Partner notification: high potential but limited implementation
Tom Platteau, HIV/STI clinic of the Institute of Tropical Medicine in Antwerp

Parallel Session 1: Monitoring and Evaluation

PS1/01 High contribution, low public funding: Southern European Checkpoints’ role in HIV detection in 4 countries
Miguel Rocha

PS1/02 HIV dynamics in the most affected area of Europe: a tale of two countries
Lise Marty

PS1/03 “Routine testing” as primary reason for getting tested for HIV in MSM: results from the first participants enrolled in the COBA-Cohorts project
Nicolas Lorente

PS1/04 National multi-stakeholder produced standards for HIV partner notification improve outcomes
Ann K. Sullivan

PS1/05 Independent of injecting drug use, being a foreign national is associated with risk of reactive HCV screening in European community-based testing services in 2017
Anna Conway

Parallel Session 2: Combination Prevention

PS2/01 On Social Media Mining for HIV Pre-Exposure Prophylaxis
Christine Kakalou

PS2/02 HIV infection and associated risk factors among Female (Cis & Trans) and Male Sex Workers in Greece: Innovative evidence by “Red Umbrella Athens”
Maria Xanthaki

PS2/03 A nationwide combination prevention success in England: intensified testing and earlier treatment controls HIV transmission in men-who-have-sex-with-men as well as benefiting others
Noel Gill

PS2/04 Programmatic Mapping and Size Estimation of Key Populations in two major cities in Turkey: Istanbul and Ankara
Deniz Gokengin

PS2/05 Contribution of anonymous partner notification service on HIV/sexual transmitted infection (STI) detection at a community-based sexual health centre for men who have sex with men (MSM)
Miguel Rocha

Plenary Session, Round Table Discussion: Fast Track Cities Initiatives: How to expand to other diseas areas

HIV stigma and testing – can global/regional initiatives help push the agenda?
Yusef Azad, National AIDS Trust

Short interventions on local experiences: Successful models for 90-90-90 for HIV and TB, community involvement and municipal leadership
Tetiana Deshko, Ukrainian Alliance for Public Health
Maia Tsereteli, HIV/AIDS, Hepatitis, STI & TB Division at the National Center for Disease Control and Public Health Georgia

Plenary Session: EU Health Project Symposium: Integrated Testing and Synergies

Service integration – Reaching the homeless population
John S. Lambert, HepCARE

Options for integrated TB, HIV and hepatitis service delivery in Romania
Gerard de Vries, E-detect TB

INTEGRATE JA: Innovation of disease specific tools into an integrated ICT combination prevention tool
Lella Cosmaro, Lila Milano/INTEGRATE

Integrated testing and services to people who use drugs
Alexandra Gurinova, HA-React

Staff training: A way to strengthen integrated prevention and health care for MSM
Matthias Kuske, Deutche AIDS Hilfe & Barrie
Dwyer Terrence Higgins Trust, Esticom

Wednesday, 30 January 2019

Plenary Special Session: The Elimination of HIV and Hepatitis Agenda: What needs to be done?

Short report from Conference Day 1
Daniel Simões

Possibilities with new testing algorithms and technologies
Anita Sands, WHO Geneva

Micro-elimination of hepatitis in prisons
Fadi Meroueh, Unité Sanitaire de la Maison d’Arrêt de Villeneuve-lès- Maguelone (USMAV)

Testing as part of HCV elimination stategies - finding the missing millions
Francesco Negro, Geneva UniversityHospital/The European Association for the Study of the Liver (EASL) Governing Board

Parallel Session 3: Integrated Testing Strategies

PS3/01 The ENABLE study; High prevalence of undiagnosed blood borne virus infections (HBV, HCV, HIV) in urban emergency department attenders in England – a case for opportunistic testing?
Zameer Mohamed

PS3/02 SH:24 – An online sexual health service using digital technology to increase access to HIV testing in London
Gillian Holdsworth

PS3/03 Tuberculosis in the time of HIV: what impede the injecting drug users (IDUs) from Romania to address diagnosis and treatment services for TB? Results from a mixed methods study
Ludmilla Verdes

PS3/04 Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review
Lara Tavoschi

PS3/05 Evidence-based public health guidance for integrated HBV, HCV and HIV testing in Europe
Ann K. Sullivan

Parallel Session 4: Linkage to Care

PS4/01 Hepcheck- Enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening
John S. Lambert

PS4/02 HepLink: Findings from a Multi-centre Observational Study in Primary and Community Care
Irina Ianache

PS4/03 Processes of data collection on HIV, viral hepatitis and STI testing and linkage to care at national level in European countries: a review for the INTEGRATE Joint Action
Anna Conway

PS4/04 Community-based HIV testing in Europe: a systematic review
Sara Croxford

PS4/05 Can We Report the Status of a Cascade of Care for Viral Hepatitis B and C in Romania? The Experience of Baylor Foundation’s Hepatitis Screening and Care Program in Dobrogea Region between 2010 - 2018
Ane-Maria Schweitzer

Plenary Session 3: Linkage to Care and Challenges in Monitoring

Defining linkage to care and challenges in monitoring
Valerie Delpech, Public Health England

Engaging with key populations; testing and linkage to care in primary care and community settings
Margaret Hellard, The Burnet Institute

Community Based Testing as part of the National formal strategies for early diagnosis and treatment of HIV/STI and Viral Hepatitis
Jordi Casabona, Catalan Public Health Agency (CEEISCAT)

The role of civil society in the integration of services and linkage to care in key populations
Eberhard Schatz, Correlation Network

Closing Session: Integration of Services

Integration of services in the personalized medicine agenda: Integrating disease areas and settings
Jens Lundgren, CHIP, Rigshospitalet, University of Copenhagen

Quality of Life and Participation and integration of patient voices in decision making and the response to HIV and Viral Hepatitis
Ricardo Baptista Leite, Member of Portuguese Parliament

Quality of life indicators
Richard Harding, Kings´s College London

Challenges ahead in Eastern Europe and Central Asia
Michel Kazatchkine, UN and Graduate Institute, Geneva, Switzerland

POSTERS

PO1/PS1: Monitoring and Evaluation

PO1/01 Impact of Adam´s Love Online-to-Offline (O2O) model in monitoring and evaluation of HIV prevention cascade among men who have sex with men (MSM)

PO1/02 Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study

PO1/03 Missed opportunities for HIV testing of patients diagnosed with an indicator condition in primary care in Catalonia, Spain

PO1/04 New diagnoses of HIV in Catalonia and socieconomic inequalities: Spatial-temporal representation with ring maps

PO1/05 Hepcare Europe Manifesto

PO1/06 HIV prevalence and associated risk factors among Men who have Sex with Men (MSM) in Greece: A community-based approach

PO1/07 Second generation HIV surveillance in people asking for HIV testing for preventive reason in Slovakia

PO1/08 Hepatitis C prevalence in Bulgaria – A stand-alone prevalence survey in the general population

PO1/09 An International Collaboration on Hepatitis C Elimination in HIV – Coinfection (InCHEHC) – a cohort profile

PO1/10 Gilead Sciences’ Commitment to Global Elimination of Hepatitis C Virus

PO1/11 A threshold analysis for the cost-effectiveness of hepatitis B and hepatitis C testing in emergency departments in the UK

PO1/12 Results of HIV, HCV and HBV rapid testing among key populations in Lviv region, Ukraine

PO1/13 Pilot HIV/HCV rapid testing project for policemen in Lviv region of Ukraine

PS1/01 High contribution, low public funding: Southern European Checkpoints’ role in HIV detection in 4 countries

PS1/02 HIV dynamics in the most affected area of Europe: a tale of two countries

PS1/03 “Routine testing” as primary reason for getting tested for HIV in MSM: results from the first participants enrolled in the COBA-Cohorts project

PS1/04 National multi-stakeholder produced standards for HIV partner notification improve outcomes

PS1/05 Independent of injecting drug use, being a foreign national is associated with risk of reactive HCV screening in European community-based testing services in 2017

PO2/PS2: Combination Prevention

PO2/01 Having to tell: Mandatory disclosure of being HIV+ in healthcare settings in the WHO European region

PO2/02 Workshop: Community Designed Tool Kit to Integrate HCV Testing in HR Programs

PO2/03 Let´s talk about Sex: HIV/STI prevention in medical practice. Promoting testing and diagnosis via communication trainings for doctors and medical students. A cooperation project by Deutsche AIDS-Hilfe, medical associations, the Federal Centre for Health Education (BZgA) and universities

PO2/04 Electronic Directly Observed Therapy (e-DOT) for PrEP adherence among Thai men who have sex with men: a feasibility randomized controlled trial

PO2/05 Esticom: Developing a Training Programme to help improve the skills and knowledge of Community Health Workers working with MSM on HIV, STI and Viral Hepatitis

PO2/06 Informal PrEP use in a cohort of MSM in Southern Spain

PO2/07 Does Pre-test Counselling Increase Specific Types of Knowledge about Transmission of HIV and Viral Hepatitis B and C?

PO2/08 ESTICOM Trainings for Community Health Worker (CHW) in Europe: first results of the Europeanwide training programme for CHW that work in the gay community

PO2/10 Incidence of sexually transmitted infections before and after pre-exposure and postexposure prophylaxis for HIV

PO2/11 Stigma and the HIV response among HIV-negative men who have sex with men in The Netherlands: new evidence from the 2018 Survey of Men and Sexuality (SMS)

PS2/01 On Social Media Mining for HIV Pre-Exposure Prophylaxis

PS2/02 HIV infection and associated risk factors among Female (Cis & Trans) and Male Sex Workers in Greece: Innovative evidence by “Red Umbrella Athens”

PS2/03 A nationwide combination prevention success in England: intensified testing and earlier treatment controls HIV transmission in men-who-have-sex-with-men as well as benefiting others

PS2/04 Programmatic Mapping and Size Estimation of Key Populations in two major cities in Turkey: Istanbul and Ankara

PS2/05 Contribution of anonymous partner notification service on HIV/sexual transmitted infection (STI) detection at a community-based sexual health centre for men who have sex with men (MSM)

PO3/PS3: Integrated Testing and Care

PO3/01 After the trial is over: effective implementation of the RHIVA2 research programme promoting HIV testing and diagnosis in east London primary care

PO3/02 The Greek "Checkpoint" success story in safeguarding public health: First community-based prevention and testing centre in Greece diagnoses 30% of the 2017 national HIV cases

PO3/03 Implementation of HIV infection hospital-based active case finding in Sardina, Italy: Results from the shot project

PO3/04 A qualitative study of acceptability of rapid screening for HIV, Hepatitis B, and Hepatitis C among migrants in France (STRADA study)

PO3/05 Low access to HIV and HCV testing among People Who Inject Drugs (PWID) in Poland. Cross-sectional multicenter study 2017

PO3/06 How can we test for HIV, HCV and syphilis – experience from Polish NGO

PO3/07 Evaluation of a new strategy for screening migrants: the STRADA study design

PO3/08 S.A.M: the new homesampling service in Germany

PO3/09 The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK

PO3/10 Two years on the road to Meet, Test and Treat Sex Workers in Rome: the need for targeted interventions

PO3/11 2017 analysis from the community checkpoint in Cologne: Are we reaching the at risk patient populations for HIV and other sexually transmitted diseases (STIs)?

PO3/12 Prevention and promotion of welfare: the importance of conducting community screenings for HIV infection

PS3/01 The ENABLE study; High prevalence of undiagnosed blood borne virus infections (HBV, HCV, HIV) in urban emergency department attenders in England – a case for opportunistic testing?

PS3/02 SH:24 – An online sexual health service using digital technology to increase access to HIV testing in London

PS3/03 Tuberculosis in the time of HIV: what impede the injecting drug users (IDUs) from Romania to address diagnosis and treatment services for TB? Results from a mixed methods study

PS3/04 Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review

PS3/05 Evidence-based public health guidance for integrated HBV, HCV and HIV testing in Europe

PO4/PS4: Linkage to Care

PO4/01 HIV self-sampling and self-testing in Europe: a systematic review

PO4/02 HepCare Europe – HCV screening and linkage to care in key populations from the Romanian clinical site

PO4/03 Adherence to Antiretroviral Treatment among the People Living with HIV in Armenia

PO4/04 Case Management Program for HIV among MSM in Kyiv, Ukraine and linkage to care, at the context the implementation of UNAIDS 90-90-90 Strategy

PO4/05 Micro-elimination as a strategy for improved access to testing and linkage to care for viral hepatitis C amongst high-risk groups in Europe

PO4/06 „Be my buddy“ How peer educators can support linkage to care and fight stigma

PO4/07 1 million rapid HIV tests: results of innovative AHF testing and linkage to care programs across Europe